We are live on ! Find out more
RKDA icon

Arcadia Biosciences
RKDA

14 hedge funds and large institutions have $222K invested in Arcadia Biosciences in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

8% more funds holding

Funds holding: 13 → 14 (+1)

0.15% less ownership

Funds ownership: 5.73% → 5.58% (-0.15%)

38% less capital inflows, than outflows

Capital inflows: $14.8K | Capital outflows: $23.8K

Holders
14
Holders Change
+1
Holders Change %
+7.69%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Mariner
Mariner
Kansas
+$10.7K
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$2.16K
3
Tower Research Capital (TRC)
Tower Research Capital (TRC)
New York
+$1.89K
4
Larson Financial Group
Larson Financial Group
Missouri
+$4
5
Morgan Stanley
Morgan Stanley
New York
+$4

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$23.3K
2
Osaic Holdings
Osaic Holdings
Arizona
-$444

RKDA Hedge Fund Activity: Q1 2025 in Review

14 of the 7,488 institutional investors tracked by Wall St. Rank reported a position in Arcadia Biosciences (RKDA) for Q1 2025, worth a combined $222K — down 52% from $465K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new RKDA positions and 1 closed out — a net gain of 1 holder — while 3 added to existing stakes and 1 trimmed.

The largest buyer was Mariner, adding an estimated $10.7K. The largest seller was UBS Group, cutting an estimated $23.3K.

  • 14 institutional investors held Arcadia Biosciences (RKDA) as of Q1 2025, up from 13 in Q4 2024.
  • Funds reported $222K of Arcadia Biosciences stock for Q1 2025, down 52% quarter-over-quarter.
  • 2 funds opened new Arcadia Biosciences positions in Q1 2025 and 1 closed out, a net change of +1 holder.
  • The largest Arcadia Biosciences buyer in Q1 2025 was Mariner, an estimated $10.7K added.
  • The largest Arcadia Biosciences seller in Q1 2025 was UBS Group, an estimated $23.3K sold.

Based on aggregated 13F filings for Q1 2025.